Ken Gelhaus has served as our Chief Commercial Officer since November 2021. Prior to joining Teknova, he was Vice President/General Manager at BD Biosciences from August 2018, with responsibility for the global clinical solutions business. Before joining BD Biosciences, Ken held roles of increasing responsibility during a 7-year tenure at Danaher Corporation, involving marketing, strategy development, acquisition integration, commercial operations, and sales. He began his career in manufacturing operations at Genentech, where he worked from 2005 to 2009. Ken holds a bachelor’s degree in biochemistry from the University of Michigan and an MBA in marketing, finance, and health enterprise management from the Kellogg School of Management, Northwestern University.
Chief Commercial Officer